NCT00211445View on ClinicalTrials.gov

Photodynamic Therapy Using Verteporfin for Treatment of Chronic Central Serous Chorioretinopathy (CSC)

PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

July 31, 2002

Study Completion Date

January 31, 2006

Conditions
Chronic Central Serous Chorioretinopathy
Interventions
PROCEDURE

Photodynamic Therapy with Verteporfin

DRUG

verteporfin

Trial Locations (1)

10021

Manhattan Eye, Ear & Throat Hospital, New York

All Listed Sponsors
lead

Manhattan Eye, Ear & Throat Hospital

OTHER

NCT00211445 - Photodynamic Therapy Using Verteporfin for Treatment of Chronic Central Serous Chorioretinopathy (CSC) | Biotech Hunter | Biotech Hunter